For instance, FH genetic testing falls under the CDC’s Office of Public Health Genomics’ Tier 1 genomic applications because clinical practice guidelines based on systematic review support genomic/genetic testing for FH among individuals whose relatives are diagnosed with FH [11,12]. This evidence concerns the gene FH and familial hyperaldosteronism.